Oral anticoagulation after atrial fibrillation catheter ablation: benefits and risks.

Koshiro Kanaoka Taku Nishida Yoshitaka Iwanaga Michikazu Nakai Reina Tonegawa-Kuji Yuichi Nishioka Tomoya Myojin Katsuki Okada Tatsuya Noda Kengo F Kusano Yoshihiro Miyamoto Yoshihiko Saito Tomoaki Imamura

Published in: European heart journal (2024)

This observational study suggests that the benefits and risks of continuing OAC therapy after CA for AF differ based on the patient's CHADS2 score. The risk of major bleeding due to OAC continuation seems to outweigh the risk reduction of thromboembolism in patients with lower thromboembolic risk.

Keyphrases

atrial fibrillation
catheter ablation
left atrial
oral anticoagulants
left atrial appendage
direct oral anticoagulants
heart failure
percutaneous coronary intervention
stem cells
coronary artery disease
venous thromboembolism
mitral valve
bone marrow